Literature DB >> 6100421

In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.

K Katsu, K Kitoh, M Inoue, S Mitsuhashi.   

Abstract

E-0702 is an antipseudomonal cephalosporin derivative which has a broad spectrum of antibacterial activity against clinical isolates of gram-positive and gram-negative bacteria. Its in vitro antibacterial activities were less than those of cefoperazone and cefotaxime against Staphylococcus aureus and Staphylococcus epidermidis, but were significantly high against gram-negative bacteria including the Pseudomonas group. It was most characteristic that E-0702 showed high antibacterial activity against Pseudomonas aeruginosa. E-0702 was relatively stable to inactivation by plasmid-mediated penicillinases and cephalosporinases produced by gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6100421      PMCID: PMC183706          DOI: 10.1128/AAC.22.2.181

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Plasmid-mediated penicillin beta-lactamases in Pseudomonas aeruginosa.

Authors:  Y Sawada; S Yaginuma; M Tai; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Biochemical properties of a penicillin beta-lactamase mediated by R factor from Bordetella bronchiseptica.

Authors:  S Yaginuma; N Terakado; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

3.  R-factor-mediated beta-lactamases that hydrolyze oxacillin: evidence for two distinct groups.

Authors:  J W Dale; J T Smith
Journal:  J Bacteriol       Date:  1974-08       Impact factor: 3.490

4.  Comparison of assay techniques for beta-lactamase activity.

Authors:  G W Ross; K V Chanter; A M Harris; S M Kirby; M J Marshall; C H O'Callaghan
Journal:  Anal Biochem       Date:  1973-07       Impact factor: 3.365

5.  A direct spectrophotometric assay and determination of Michaelis constants for the beta-lactamase reaction.

Authors:  A Samuni
Journal:  Anal Biochem       Date:  1975-01       Impact factor: 3.365

6.  Purification and properties of a cephalosporinase from Enterobacter cloacae.

Authors:  S Minami; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

7.  Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins.

Authors:  K Sato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

8.  Purification and properties of a new beta-lactamase from Pseudomonas cepacia.

Authors:  K Hirai; S Iyobe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

9.  Purification and properties of cephalosporinase from Pseudomonas aeruginosa.

Authors:  T Murata; S Minami; K Yasuda; S Iyobe; M Inoue; S Mitsuhashi
Journal:  J Antibiot (Tokyo)       Date:  1981-09       Impact factor: 2.649

10.  Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri.

Authors:  M Matsuura; H Nakazawa; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

View more
  15 in total

1.  In vitro antibacterial activity of KP-736, a new cephem antibiotic.

Authors:  T Maejima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system.

Authors:  N A Watanabe; T Nagasu; K Katsu; K Kitoh
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

3.  Cir and Fiu proteins in the outer membrane of Escherichia coli catalyze transport of monomeric catechols: study with beta-lactam antibiotics containing catechol and analogous groups.

Authors:  H Nikaido; E Y Rosenberg
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

4.  Antibacterial activity of BMS-180680, a new catechol-containing monobactam.

Authors:  J Fung-Tomc; K Bush; B Minassian; B Kolek; R Flamm; E Gradelski; D Bonner
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols.

Authors:  Mark E Flanagan; Steven J Brickner; Manjinder Lall; Jeffrey Casavant; Laura Deschenes; Steven M Finegan; David M George; Karl Granskog; Joel R Hardink; Michael D Huband; Thuy Hoang; Lucinda Lamb; Andrea Marra; Mark Mitton-Fry; John P Mueller; Lisa M Mullins; Mark C Noe; John P O'Donnell; David Pattavina; Joseph B Penzien; Brandon P Schuff; Jianmin Sun; David A Whipple; Jennifer Young; Thomas D Gootz
Journal:  ACS Med Chem Lett       Date:  2011-03-02       Impact factor: 4.345

6.  In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.

Authors:  N Watanabe; R Hiruma; K Katsu
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

7.  In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.

Authors:  N Watanabe; K Katsu; M Moriyama; K Kitoh
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

8.  In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

Review 9.  Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents.

Authors:  Marvin J Miller; Helen Zhu; Yanping Xu; Chunrui Wu; Andrew J Walz; Anne Vergne; John M Roosenberg; Garrett Moraski; Albert A Minnick; Julia McKee-Dolence; Jingdan Hu; Kelley Fennell; E Kurt Dolence; Li Dong; Scott Franzblau; Francois Malouin; Ute Möllmann
Journal:  Biometals       Date:  2009-01-07       Impact factor: 2.949

10.  In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.

Authors:  M Arisawa; Y Sekine; S Shimizu; H Takano; P Angehrn; R L Then
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.